Pharma Archive
21 October 2025
Guidelines for Pharmaceutical Companies to Prevent Commercial Bribery Risks
15 October 2025
Administrative Measures for the Import of Drugs (2012 Amendment)
14 October 2025
Announcement of the National Medical Products Administration, Ministry of Finance, and State Administration for Market Regulation on Rewards for Internal Informants Reporting Issues Concerning the Quality and Safety of Medicinal Products and Medical Devices (2025)
9 October 2025
The Department of Health establishes Preparatory Office for Hong Kong Centre for Medical Products Regulation (2024)
9 October 2025
The General Office of the State Council’s Opinions on Deepening the Reform of Drug and Medical Device Regulation and Promoting the High-Quality Development of the Pharmaceutical Industry (2024)
9 October 2025
Notice by the China National Medical Products Administration of Issuing the Pilot Work Plan for Optimizing the Review and Approval of Clinical Trials of Innovative Drugs (2024)
19 September 2025
The General Office of the State Council’s Notice on Printing and Distributing the Key Tasks for Deepening the Reform of the Medical and Health System in 2024
18 September 2025
Notice by the National Healthcare Security Administration and the National Health Commission on Improving the Mechanism for Centralized Pharmaceutical Procurement and its Implementation (2024)
18 September 2025
Announcement of the National Medical Products Administration and the National Intellectual Property Administration on Issuing the Implementation Measures for the Mechanism for Early Settlement of Drug Patent Disputes (2021)
17 September 2025